MoneyWorks4Me

Dr Lal Pathlabs informs about analyst meetings

04 Sep 2018 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr Lal Pathlabs has informed about the details of proposed schedule of Analyst/Institutional Investor meetings.

The above information is a part of company’s filings submitted to BSE.

 

Peers